ARCHIVES

Daniel Hayes Elected President of ASCO

This article is from The Cancer Letter archive.

Vol. 40 No. 46 | December 12, 2014

Download PDF Visit The Full Archive

Related Articles

Chemoprevention, Immunotoxicolgy RFAs Available

June 5, 1981

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

NCI Deputy Barker Hits FDA, Calls for New Incentives for Pharmaceutical Industry; Barker Co-Founded Dietary Supplements Firm

May 30, 2003

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991

NCI “Month” Appropriate For May, With Several Major Decisions Pending got Start Next 50 Years

May 1, 1987

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002